HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- oxydiethylenethiocarbamoyl- N- oxydiethylene sulfenamide

structure in first source

Also Known As:

OTOS

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Oxazines: 9
    - N-oxydiethylenethiocarbamoyl-N-oxydiethylene sulfenamide: 5

Experts

1.	Dalvie, Sameera: 1 article (09/2014)
2.	Ramesar, Rajkumar S: 1 article (09/2014)
3.	Ramma, Lebogang: 1 article (09/2014)
4.	Spracklen, Timothy F: 1 article (09/2014)
5.	Vorster, Anna Alvera: 1 article (09/2014)
6.	Whitehorn, Heather: 1 article (09/2014)
7.	Wang, Yan: 1 article (06/2008)
8.	Wei, Yun-Jun: 1 article (06/2008)
9.	Zhang, Xue-Yuan: 1 article (06/2008)
10.	Zhang, Yun-Song: 1 article (06/2008)

Related Diseases

1.	Ototoxicity 09/01/2014 - "The G alleles of Otos rs77124181 (c.-192-182C>G) and rs2291767 (c.-192-22A>G) were over-represented in ototoxicity-free patients (p = 0.022). " 09/01/2014 - "This study indicates a potentially protective role for the variant G alleles of SNPs rs77124181 and rs2291767 in Otos against the development of cisplatin-induced ototoxicity." 09/01/2014 - "Given the reported in vitro protective role of the gene Otos in response to cisplatin, this study aimed to explore the potential of Otos as a genetic modifier of ototoxicity. " 09/01/2014 - "Genetic variation in Otos is associated with cisplatin-induced ototoxicity."
2.	Deafness (Deaf Mutism) 01/01/2005 - "We now have generated mice with deletion of Otos and found that they show moderate deafness, with no frequency predominance. " 06/03/2008 - "As expected, the data showed that Otos up-regulation significantly decreased apoptosis of SLFs induced by DDP possibly through activation of ERK and partial inhibition of JNK and mitochondrial pathway but not p-38 pathway, suggesting Otos as a potential protective gene for cochlea and raising the possibility of Otos up-regulation as a promising approach to DDP-induced deafness therapy."
3.	Otitis Media 09/01/2023 - "We compared adherence rates by attending otolaryngologists (OTOs) and advanced practice providers (APPs) to the 2013 American Academy of Otolaryngology-Head and Neck Surgery Foundation clinical practice guideline (CPG) for children with recurrent acute otitis media (RAOM) undergoing bilateral myringotomy and tympanostomy tube placement (BMT). "
4.	Neoplasms (Cancer) 09/01/2014 - "One hundred South African cisplatin-receiving cancer patients with baseline and follow-up audiometric data were screened for variation in exonic target regions of Otos using direct cycle sequencing. "
5.	Ankyloglossia 08/31/2000 - "Sixty-seven percent of OTOs versus 21% of PDs believe tongue-tie is at least sometimes associated with social/mechanical issues. " 08/31/2000 - "Sixty percent of OTOs, 50% of SPs, but only 23% of PDs believe tongue-tie is at least sometimes associated with speech difficulties. "

Related Drugs and Biologics

1.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Therapeutics
2.	Middle Ear Ventilation (Tympanostomy)